semaglutide weight loss fda approval Novo Nordisk's weight-loss pill wins FDA Approves First GLP-1 Weight

By mimicking the natural effects of GLP-1, these medications offer a new avenue for those struggling with obesity or overweight, providing not only improved appetite control and satiety but also better blood sugar regulation

One woman reported paying just $300 per month for her prescription, which originally cost over triple that amount before switching from Ozempic to a generic version

Type 2 Diabetes Treatment Semaglutide may work to promote insulin production

CLICK HERE FOR MORE HEALTH STORIES If a GLP-1 patient becomes too fatigued to exercise, develops nutritional deficiencies or loses excessive muscle mass, Kahn warned that this reflects a "monitoring problem" rather than a medication problem, as these medications "require close clinical oversight."